BridgeMD
New treatment option for Non-Alcoholic Fatty Liver Disease
Official title Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov ID: NCT07294963
What this study is testing
- What it's testing
- This study investigates whether a structured lifestyle program can help improve thinking skills and liver health in adults with Non-Alcoholic Fatty Liver Disease (NAFLD). We are enrolling 45 participants, aged 18-42, who will be randomly assigned to one of three groups for six months: one receiving general health advice, a second following a supervised Mediterranean diet plan, and a third combining the same diet with a regular walking program.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 42
You may be able to join if
- Age 18 to 42 years.
- Diagnosed with fatty liver (NAFLD) via imaging (e.g., ultrasound).
- Liver fibrosis assessed and staged via FibroScan and the FIB-4 index.
- Literate (to consent and complete cognitive assessments/questionnaires).
You likely can't join if
- History of alcohol intake \>20g/day.
- Chronic viral hepatitis B or C.
- Major neuropsychiatric illnesses.
- Pregnancy or breastfeeding.
- Chronic illnesses including Diabetes Mellitus and thyroid dysfunction.
The study team makes the final eligibility decision.
Where it's taking place
- Peshawar, KPK, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 42 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Peshawar, KPK, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.